Preferred Label : parathyroid hormone;
MeSH definition : A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS
which performs the essential role of maintaining intracellular CALCIUM levels in the
body. Parathyroid hormone increases intracellular calcium by promoting the release
of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the
renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.;
MeSH synonym : pth (1-84); hormone, parathyroid; parathyrin; parathyroid hormone (1-84); parathormone;
CISMeF acronym : PTH;
MeSH hyponym : parathyroid hormone peptide (1-34); Parathyroid Hormone (1-34); PTH(1-34);
MeSH annotation : /defic: consider also HYPOPARATHYROIDISM;
Wikipedia link : https://en.wikipedia.org/wiki/Parathyroid hormone;
Is substance : O;
Origin ID : D010281;
UMLS CUI : C0030520;
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
False automatic mappings
Indexing information
Manual BTNT mappings - CISMeF
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- ZP2307 [MeSH Supplementary Concept]
- ZT-031 [MeSH Supplementary Concept]
See also
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS
which performs the essential role of maintaining intracellular CALCIUM levels in the
body. Parathyroid hormone increases intracellular calcium by promoting the release
of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the
renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.
https://www.has-sante.fr/jcms/p_3293932/fr/iqss-2024-evenements-thrombo-emboliques-apres-pose-de-prothese-totale-de-hanche-ete-pth
2024
France
technical report
embolus, nos
hip prosthesis
embolus
embolism
parathyroid hormone
fitting of prosthesis, nos
prosthesis implantation
thromboembolism
hip prosthesis
---
https://www.has-sante.fr/jcms/p_3294825/fr/iqss-2022-infections-du-site-operatoire-apres-pose-de-prothese-totale-de-hanche-iso-pth
2024
France
technical report
parathyroid hormone
infectious disease, nos
surgical wound infection
hip prosthesis
operative site, nos
Infections
prosthesis implantation
Infectious disease
fitting of prosthesis, nos
hip prosthesis
---
https://www.has-sante.fr/jcms/p_3293932/fr/iqss-2022-evenements-thrombo-emboliques-apres-pose-de-prothese-totale-de-hanche-ete-pth
2024
France
technical report
embolus, nos
Embolism
hip prosthesis
thromboembolism
prosthesis implantation
hip prosthesis
embolism
parathyroid hormone
embolus
fitting of prosthesis, nos
---
https://www.has-sante.fr/jcms/p_3165703/fr/movymia-pen
2020
false
false
false
France
health technology assessment
parathyroid hormone, nos
parathyroid hormone
injector, nos
---
Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy
hypoparathyroidism
https://www.cochrane.org/fr/CD012845/calcium-vitamine-d-ou-hormone-parathyroidienne-recombinante-pour-le-traitement-de-lhypoparathyroidie
2019
false
false
false
France
United Kingdom
hypoparathyroidism
dietary supplements
treatment outcome
Evidence-Based medicine
review of literature
french abstract
parathyroid hormone
vitamin D
thyroidectomy
hypoparathyroidism
calcium
---
https://www.has-sante.fr/portail/jcms/c_2888453/fr/natpar
https://www.has-sante.fr/portail/jcms/c_2888453/fr/natpar-hormone-parathyroidienne-recombinante
2018
false
false
false
France
parathyroid hormone
injections, subcutaneous
parathyroid hormone
hypoparathyroidism
treatment outcome
insurance, health, reimbursement
adult
aged
chronic disease
guidelines for drug use
recombinant proteins
evaluation of the transparency committee
---
https://pharmacomedicale.org/medicaments/par-specialites/item/derives-de-la-parathormone
2017
false
false
false
France
osteoporosis
teriparatide
osteoporosis, postmenopausal
parathyroid hormone
drug information
parathyroid hormone
---
https://www.ema.europa.eu/medicines/human/EPAR/Natpar
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
treatment outcome
adult
hypoparathyroidism
parathyroid hormone
parathyroid hormone
product surveillance, postmarketing
chronic disease
injections, subcutaneous
aged
continuity of patient care
drug monitoring
drug interactions
pregnancy
breast feeding
parathyroid hormone
drug evaluation, preclinical
---
https://anpgm.fr/media/documents/ANPGM_113_Resistance_PTH_avec_ou_sans_OHA.doc
2012
France
guideline
Pseudohypoparathyroidism
osseous heteroplasia, progressive
pseudohypoparathyroidism
Osteodystrophia
hip prosthesis
acrodysostosis
parathyroid hormone
acrodysostosis
pseudohypoparathyroidism, nos
diffuse rigidity
Progressive osseous heteroplasia
fibrous dysplasia, polyostotic
bone diseases, metabolic
ossification, heterotopic
skin diseases, genetic
dysostoses
intellectual disability
osteochondrodysplasias
---
https://www.ema.europa.eu/medicines/human/EPAR/preotact
2012
false
United Kingdom
French
English
syndication feed
osteoporosis, postmenopausal
parathyroid hormone
parathyroid hormone
treatment outcome
drug evaluation
recombinant proteins
recombinant proteins
drug approval
drug labeling
injections, subcutaneous
drug evaluation, preclinical
drug storage
spinal fractures
parathyroid hormone
package leaflet
summary of product characteristics
drug evaluation
---
http://revmed.ch/RMS/2005/RMS-35/30681
2005
Switzerland
French
injections, subcutaneous
bone remodeling
fractures, bone
teriparatide
bone density conservation agents
treatment outcome
parathyroid hormone
bone density conservation agents
osteoporosis
parathyroid hormone
parathyroid hormone
drug information
journal article
---